Clinical Trials
6 trialsNCT06618391 2024-10-01
Local Injection and Systemic Therapy in the Treatment of NSCLC.
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT05068427 2024-08-07
Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.
Chipscreen Biosciences, Ltd.
Phase 2 Completed
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT05414630 2022-06-10
A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer
Anhui Provincial Cancer Hospital
Phase 2 Unknown
NCT05360979 2022-05-04
A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC
Second Xiangya Hospital of Central South University
Phase 2 Unknown
NCT05055167 2021-09-24
Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC
The First Affiliated Hospital of Xiamen University
Phase 2 Unknown